Cadre (CDRE) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
20 May, 2026Executive summary
Q1 2026 net sales rose 19–19.5% year-over-year to $155.4 million, driven by acquisitions and strong demand in law enforcement, first responder, military, and nuclear markets.
Orders backlog reached a record $355–$355.4 million, up $165.6–$166 million from year-end, reflecting new contracts, EOD orders, and acquisitions.
Net income for Q1 2026 was $2.0 million ($0.05 per diluted share), down 78.6% year-over-year due to higher compensation, interest, and transaction expenses.
Adjusted EBITDA increased to $21.1 million (up 3% year-over-year), with a margin of 13.6%.
Major acquisitions included TYR Tactical ($175–$185.2 million) and Alien Gear Holsters ($10–$10.3 million), supporting multi-vertical expansion.
Financial highlights
Q1 2026 net sales: $155.4 million (up 19–19.5% year-over-year); gross profit: $60.2 million; gross margin: 38.7% (down from 43.1% year-over-year).
Adjusted EBITDA: $21.1 million (up from $20.5 million year-over-year); margin: 13.6% (down from 15.8% year-over-year).
Net income: $2.0 million; operating income: $7.5 million (down from $13.6 million year-over-year).
Cash and cash equivalents at quarter-end: $41.3 million, down from $122.9 million at year-end 2025.
Total debt rose to $365.8 million from $307.3 million at year-end.
Outlook and guidance
Full-year 2026 net sales guidance: $736–$758 million; Adjusted EBITDA: $136–$141 million; capital expenditures: $10–$14 million.
Organic revenue growth expected in the 3%–5% range for 2026.
Management expects continued growth from acquisitions and backlog, with 44% of remaining performance obligations to be recognized within 12 months.
Liquidity considered sufficient for at least the next 12 months, supported by cash flows and available credit.
Second half of 2026 expected to account for about 55% of full-year revenue, with higher margins due to operating leverage and large order shipments.
Latest events from Cadre
- Strong Q2 2026 results and raised FY2026 outlook reflect robust growth and successful M&A.CDRE
Investor presentation - Q2 2026 net sales rose 32%, with record backlog and raised guidance on strong demand.CDRE
Q2 2026 - Record backlog and robust growth in safety and nuclear markets drive strong 2026 outlook.CDRE
Investor presentation - Supplement amends 2025 executive compensation details; all other proxy matters remain unchanged.CDRE
Proxy filing - Proxy covers director elections, auditor ratification, executive pay, and governance practices.CDRE
Proxy filing - Strong FY2025 results and disciplined M&A fuel growth, with FY2026 sales guidance up to $758M.CDRE
Investor presentation - Record EBITDA and net income growth in 2025, with double-digit 2026 outlook and higher dividend.CDRE
Q4 2025 - Nuclear safety and engineered products drive growth, margin expansion, and resilience.CDRE
Investor Day 2025 - Apex armor and robotics launches showcase innovation and global expansion focus.CDRE
Investor Update